Mainz Biomed announces opening of EOL

Mainz Biomed announces the opening of the ‘European Oncology Lab,’ EOL. The physician-led facility represents an expansion of the Company’s collaboration with Laboratory Dr. Buhlmann with a shared location in Saarland, Germany. Via the EOL, medical professionals or patients can now order ColoAlert directly with Mainz Biomed as a laboratory medical service, meeting a crucial requirement to invoice private health insurance companies. Darin Leigh, Chief Commercial Officer of Mainz Biomed, commented: “This expansion marks a significant milestone in our mission to make early CRC detection more accessible for patients in Germany. The ability to invoice ColoAlert as a laboratory medical service opens a new revenue growth opportunity in addition to our established commercial sales channels. Given that March is Colorectal Cancer Awareness Month, we are very excited about this new opportunity to create visibility around the importance of earlier CRC detection.”